Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMEDY Study
2009-013622-17Phase 3Active
- Sponsor
- Cardiologia Universitaria - Ospedale Clinicizzato SS. Annunziata
- Start
- Nov 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rosuvastatin, ezetimibe and atorvastatin in coronary arteriosclerosis (4 arms), sponsored by Cardiologia Universitaria - Ospedale Clinicizzato SS. Annunziata. Primary endpoints: Extent of peri-procedural myocardial infarction and Relevance of HMG-CoA reductase inhibition. Started Nov 2009; status: active.
02
Drugs
rosuvastatinezetimibeatorvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2009-013622-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013622-17.